finding,pubmed_id,finding_id
"Prevalence of hepatitis B virus (HBV) in multiple myeloma (MM) patients in China is similar to that in the general population, and there is no significant association between HBV and MM.",PMC4799569,PMC4799569_0
The response rate of bortezomib in MM patients with HBV infection is comparable to that in HBV-negative patients.,PMC4799569,PMC4799569_1
No significant association was found between HBV and MM in a nested case-control study in Europe.,PMC4799569,PMC4799569_2
The prevalence of HBV in MM patients in China is lower than that in a singapore study.,PMC4799569,PMC4799569_3
Bortezomib had no impact on HBV reactivation and liver function in MM patients.,PMC4799569,PMC4799569_4
